NASDAQ:MLEC Moolec Science (MLEC) Stock Price, News & Analysis → Bigger Than NVIDIA? (From Behind the Markets) (Ad) Free MLEC Stock Alerts $1.05 -0.05 (-4.55%) (As of 06/17/2024 ET) Add Compare Share Share Today's Range$1.02▼$1.1250-Day Range$1.06▼$2.4752-Week Range$1.02▼$4.40Volume31,575 shsAverage Volume992,187 shsMarket Capitalization$39.44 millionP/E RatioN/ADividend YieldN/APrice Target$5.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends Get Moolec Science alerts: Email Address Moolec Science MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside423.8% Upside$5.50 Price TargetShort InterestHealthy2.45% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.72Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.11 out of 5 starsConsumer Staples Sector101st out of 135 stocksHolding & Other Investment Offices Industry6th out of 16 stocks 3.5 Analyst's Opinion Consensus RatingMoolec Science has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageMoolec Science has received no research coverage in the past 90 days.Read more about Moolec Science's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted2.45% of the float of Moolec Science has been sold short.Short Interest Ratio / Days to CoverMoolec Science has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Moolec Science has recently decreased by 33.05%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldMoolec Science does not currently pay a dividend.Dividend GrowthMoolec Science does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MLEC. Previous Next 2.6 News and Social Media Coverage News SentimentMoolec Science has a news sentiment score of 0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Moolec Science this week, compared to 0 articles on an average week.Search InterestOnly 2 people have searched for MLEC on MarketBeat in the last 30 days. This is a decrease of -82% compared to the previous 30 days.MarketBeat Follows2 people have added Moolec Science to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Moolec Science insiders have not sold or bought any company stock.Percentage Held by Insiders19.90% of the stock of Moolec Science is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 0.07% of the stock of Moolec Science is held by institutions.Read more about Moolec Science's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Book Value per Share RatioMoolec Science has a P/B Ratio of 3.89. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Moolec Science's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and radically change life in America as we know it today. And a Draconian set of technologies that could impose a new kind of financial surveillance in America. Click here to learn more. About Moolec Science Stock (NASDAQ:MLEC)Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.Read More MLEC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MLEC Stock News HeadlinesJune 11, 2024 | americanbankingnews.comCC Neuberger Principal Holdings II (NYSE:PRPB) versus Moolec Science (NASDAQ:MLEC) Critical ReviewMay 31, 2024 | gurufocus.comQ3 2024 Moolec Science SA Earnings Call TranscriptMay 30, 2024 | investorplace.comMLEC Stock Earnings: Moolec Science Beats EPS for Q3 2024May 23, 2024 | finance.yahoo.comMoolec Science to Host Third Quarter Fiscal Year 2024 Business Update Conference CallMay 9, 2024 | finanznachrichten.deMediprogen Inc.: Mediprogen Has Entered Into Commercial Discussions With Moolec to Expand Their Technology Into the Cosmetics Global MarketApril 24, 2024 | msn.comImmutep, Capricor Therapeutics, Cyclacel Pharmaceuticals among healthcare moversApril 24, 2024 | seekingalpha.comMLEC Moolec Science SAApril 23, 2024 | msn.comTop 2 Risk Off Stocks You May Want To Dump In Q2April 22, 2024 | marketwatch.comMoolec Science Shares Rise 69% After USDA Approval for Plant-Grown Animal ProteinApril 22, 2024 | msn.comWhy Shares Of Moolec Science Are Skyrocketing TodayApril 22, 2024 | investorplace.comWhy Is Moolec Science (MLEC) Stock Up 121% Today?April 22, 2024 | investorplace.comWhy Is Moolec Science (MLEC) Stock Up 121% Today?March 16, 2024 | markets.businessinsider.comVendetti Reaffirms Buy Rating for Moolec Science Highlighting Strong Financials and R&D ProgressFebruary 24, 2024 | msn.comMoolec Science (MLEC) Price Target Increased by 10.00% to 5.61January 11, 2024 | msn.comDown -18.03% in 4 Weeks, Here's Why You Should You Buy the Dip in Moolec Science SA (MLEC)January 11, 2024 | investorplace.comWhy Is Moolec Science (MLEC) Stock Up 40% Today?December 23, 2023 | wsj.comMoolec Science S.A.December 18, 2023 | investorplace.comMLEC Stock Earnings: Moolec Science Reported Results for Q1 2024December 14, 2023 | msn.comMoolec Science GAAP EPS of -$0.04, revenue of $1.74MDecember 14, 2023 | finance.yahoo.comMoolec Science Presents First Quarter Fiscal Year 2024 Business UpdateDecember 7, 2023 | finanznachrichten.deMoolec Science SA: Moolec Science to Host First Quarter Fiscal Year 2024 Business Update Conference CallDecember 7, 2023 | finance.yahoo.comMoolec Science to Host First Quarter Fiscal Year 2024 Business Update Conference CallOctober 20, 2023 | finanznachrichten.deMoolec Science SA: Moolec Science Presents Fourth Quarter FY 2023 Business UpdateOctober 20, 2023 | finance.yahoo.comMoolec Science Presents Fourth Quarter FY 2023 Business UpdateOctober 17, 2023 | finance.yahoo.comMoolec Science to Host Fiscal Year 2023 Business Update Conference CallSee More Headlines Receive MLEC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Moolec Science and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/17/2024Fiscal Year End6/30/2024Next Earnings (Estimated)11/04/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Holding & other investment offices Sub-IndustryN/A Current SymbolNASDAQ:MLEC CUSIPN/A CIK1937737 Webmoolecscience.com Phone650-515-3930FaxN/AEmployees45Year FoundedN/APrice Target and Rating Average Stock Price Target$5.50 High Stock Price Target$6.00 Low Stock Price Target$5.00 Potential Upside/Downside+391.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-51,790,000.00 Net Margins-150.27% Pretax Margin-247.39% Return on Equity-87.89% Return on Assets-33.26% Debt Debt-to-Equity Ratio0.89 Current Ratio0.43 Quick Ratio0.37 Sales & Book Value Annual Sales$900,000.00 Price / Sales46.74 Cash FlowN/A Price / Cash FlowN/A Book Value$0.27 per share Price / Book4.15Miscellaneous Outstanding Shares37,560,000Free Float30,089,000Market Cap$42.07 million OptionableNot Optionable Beta-0.53 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Gaston Paladini M.B.A. (Age 43)Co-Founder, CEO & Director Mr. Henk Hoogenkamp Ph.D. (Age 37)Co-Founder & Chief Product Officer Mr. Martin Salinas Ph.D. (Age 42)Chief of Technology & Co-Founder Mr. Jose Lopez Lecube M.B.A. (Age 41)CFO & Director Mr. Amit Dhingra Ph.D. (Age 54)Chief Science Officer Ms. Catalina Jones B.A. (Age 38)Chief of Staff & Sustainability More ExecutivesKey CompetitorsFTAC Emerald AcquisitionNASDAQ:EMLDBattery Future AcquisitionNYSE:BFACRoss Acquisition Corp IINYSE:ROSSHCM AcquisitionNASDAQ:HCMAMurano Global InvestmentsNASDAQ:MRNOView All Competitors MLEC Stock Analysis - Frequently Asked Questions Should I buy or sell Moolec Science stock right now? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Moolec Science in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" MLEC shares. View MLEC analyst ratings or view top-rated stocks. What is Moolec Science's stock price target for 2024? 3 equities research analysts have issued 12 month price targets for Moolec Science's shares. Their MLEC share price targets range from $5.00 to $6.00. On average, they predict the company's stock price to reach $5.50 in the next year. This suggests a possible upside of 423.8% from the stock's current price. View analysts price targets for MLEC or view top-rated stocks among Wall Street analysts. How have MLEC shares performed in 2024? Moolec Science's stock was trading at $2.46 at the start of the year. Since then, MLEC shares have decreased by 57.3% and is now trading at $1.05. View the best growth stocks for 2024 here. Are investors shorting Moolec Science? Moolec Science saw a decrease in short interest in May. As of May 31st, there was short interest totaling 159,000 shares, a decrease of 33.1% from the May 15th total of 237,500 shares. Based on an average daily volume of 1,450,000 shares, the days-to-cover ratio is currently 0.1 days. Approximately 2.5% of the shares of the company are sold short. View Moolec Science's Short Interest. When is Moolec Science's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, November 4th 2024. View our MLEC earnings forecast. How do I buy shares of Moolec Science? Shares of MLEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MLEC) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | Sponsoredonly trade options on these 5-7 stocksI'm going to reveal the only 5-7 stocks you should be trading. But here's the secret - there's nothing spec...Prosper Trading Academy | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredInflation Is Robbing You Blind! Here’s How to Fight Back!Quietly, inflation has reduced your purchasing power by 29.4% since 2014. So something that cost $100 in 20...American Alternative | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moolec Science SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Moolec Science With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
